• Investors
    • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
      • Directory & Advisers
      • Corporate Documents
      • Board Committees & responsibilities
    • AIM Rule 26
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A Update with Zack Bozinovski
  • Contact
  • Investors
    • Investor Centre
    • Live Investor Briefing
    • Share Price and Announcements
    • Corporate Governance
      • Directory & Advisers
      • Corporate Documents
      • Board Committees & responsibilities
    • AIM Rule 26
  • About Us
  • News & media
    • Webcast Replays
      • Wellnex Life Q&A Update with Zack Bozinovski
  • Contact
WNX - WC Template (Q&A)

Wellnex Life (ASX:WNX) Q&A Zack Bozinovski – 20th February 2025

Wellnex Life (ASX:WNX): Q&A Update with Managing Director Zack Bozinovski Managing Director Zack Bozinovski provides...

WNX Q&A - WC Template (standard - RM)

Wellnex Life (ASX:WNX) Investor Briefing – 7th February 2025

Wellnex Life (ASX:WNX): Investor Briefing with Managing Director Zack Bozinovski Managing Director Zack Bozinovski provides...

WNX [Page4 - Thumbnail]

Wellnex Life (ASX:WNX) Investor Briefing – 19th December 2024

Wellnex Life (ASX:WNX): Investor Briefing with Managing Director Zack Bozinovski and Non-Executive Chairman George Tambassis...

WNX [Page 2 - Thumbnail]

Wellnex Life (ASX:WNX) Q&A – 9th February 2024

Wellnex Life (ASX:WNX): Q&A with Managing Director Zack Bozinovski and Non-Executive Chairman Mario Tascone In...

WNX [Page 1 - Thumbnail]

Wellnex Life (ASX:WNX) Investor Briefing & Q&A – 14th December 2023

Wellnex Life (ASX:WNX): Investor Briefing & Q&A with Managing Director Zack Bozinovski, CEO George Karafotias...

thu-wnx

Wellnex Life Q&A Update

AdobeStock_286427705

Unlocking the over-the-counter medicinal cannabis opportunity

Company Explainer: Unlocking the over-the-counter medicinal cannabis opportunity CEO of Wellnex Life George Karafotias, Chief...

Frame-624-1

Unlocking the over-the-counter medicinal cannabis opportunity

RECENT POSTS
  • Wellnex Life expects growth to continue through year as revenue surges
  • Wellnex Life debuts in London with successful AIM IPO
  • Sydney-listed Wellnex Life starts trading on AIM market in London
  • The London Stock Exchange Today Welcomes Wellnex Life Limited
  • Wellnex Life on track for UK listing after raising £7.3m
SHARE THIS POST
  • FB
  • Insta
  • Group 23
Home
About us
Contact us
Privacy Policy




*proposed new name change for Wattle Health Australia Limited (subject to shareholder approval)

This investor centre was built by Reach Markets

©2025 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)